No IPOs are currently scheduled for the week ahead, signaling a quiet start to the fourth quarter.
A few companies are eligible to launch in the coming week, including neocloud firm Nscale (NSCL). However, the most likely candidates are autoimmune biotech TRex Bio (TRXB) and cancer biotech Iambic Therapeutics (IAM).
Beyond the public pipeline, AI giant Anthropic (RC ticker: ANTH.RC) is reportedly firming up its listing timeline, with marketing expected as soon as the week of November 9th.
Four lock-up periods will be expiring in the week ahead. For access to lock-up expiration dates, sign up for a free trial of IPO Pro.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/1/2026, the Renaissance IPO Index was up 16.4% year-to-date, while the S&P 500 was up 13.0%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Astera Labs (ALAB) and SK hynix (SKHY). The Renaissance International IPO Index was up 28.5% year-to-date, while the ACWX was up 13.8%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Kioxia and Galderma.
